Funding · Company
Amani Therapeutics, Inc.
New York, NYHealthcare
Amani Therapeutics, Inc. of New York, NY has disclosed $31M across 1 Form D offering filed with the SEC on Dec 10, 2025.
$31M
Total disclosed
1
Form D offering
2025
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersNew York, NYIndustryHealthcare (Other Health Care)Incorporated2025SEC CIK0002099941Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →